Skip to content

An Optimized Protocol for the Generation of Vascular Organoids from Human Induced Pluripotent Stem Cells.

Sep 2026 · Journal of Visualized Experiments · Vol 235 · 0 citations
Medicine

TL;DR

This optimized method enables the scalable production of high-quality vascular organoids suitable for studying vascular cell interactions, modeling disease, and screening compounds, thereby lowering the technical barrier for laboratories seeking to adopt this model system.

Abstract

Vascular organoids derived from human pluripotent stem cells (hPSCs) have emerged as powerful three-dimensional models for studying vascular development, disease mechanisms, and drug responses. Current vascular organoid protocols enable the generation of self-organizing endothelial-pericyte networks; however, batch-to-batch variability, inconsistent organoid formation, and inadequate pericyte coverage can compromise reproducibility and scalability. This study presents an optimized protocol for generating vascular organoids from human induced pluripotent stem cells (hiPSCs) with improved reproducibility and structural consistency. Key modifications include refined embryoid body formation conditions, optimized growth factor concentrations and timing during mesoderm induction and vascular specification, and improved three-dimensional culture conditions that promote robust pericyte recruitment and endothelial-pericyte interactions. The optimized organoids exhibit highly branched CD31-positive endothelial networks consistently ensheathed by PDGFR-β-positive pericytes, with significantly reduced batch-to-batch variability compared with the original protocol. Detailed, step-by-step procedures are provided for organoid generation, whole-mount immunofluorescence characterization, and quality control assessment. This optimized method enables the scalable production of high-quality vascular organoids suitable for studying vascular cell interactions, modeling disease, and screening compounds, thereby lowering the technical barrier for laboratories seeking to adopt this model system.

View source

Similar papers

Open access Aug 2026

Comparative methods for iPSC-Derived endothelial cells in modeling vascular diseases

Endothelial cells (ECs) derived from human induced pluripotent stem cells (hiPSCs) are increasingly used to model vascular diseases and test therapeutic strategies. However, the efficiency and reproducibility of differentiation can vary depending on the culture medium and its supplemented factors and stages. Here, we d...

Pakize Nur Akkaya, L. Koolen, Zohreh Hosseinzadeh · 0 citations
Review Open access Sep 2026

From Primary Cells to Organoids: Expanding the Biological Relevance of In Vitro Cellular Models

Highlights What are the main findings? In vitro models form a continuum from primary cells and established cell lines to iPSC-derived organoids and advanced bioengineered systems, with distinct strengths and limitations in modeling human biology. Biological relevance must be balanced with reproducibility, scalability,...

Feng-Yan Deng, Yan Wang, L. Castellano et al. · 0 citations
Review Open access Sep 2026

Organoids: Current Applications and Future Directions

Organoids are three‐dimensional multicellular structures derived from stem cells or primary tissues that recapitulate key structural and functional features of native organs. Advances in stem cell biology, biomaterials, and bioengineering have established organoids as powerful platforms for studying human development a...

Yue-Qi Leng, Yue Wang, C. Cao et al. · 0 citations
Open access Oct 2026

Efficient Generation of Fetal Hepatic Stellate Cells From hiPSC

Human induced pluripotent stem cell (hiPSC)-derived liver organoids have emerged as valuable models for studying human liver development. However, existing organoid systems often lack developmentally matched cell populations, particularly fetal hepatic stellate cells (HSCs), limiting their ability to recapitulate key d...

Xia Yang, Hideki Taniguchi, Yun-Zhong Nie · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.